Women who take a popular hormone replacement drug after menopause not only increase their chances of getting breast cancer but also seem to face an increased risk of dying from the disease, according to new results of a landmark federal study.

Click on the below link to read the article that was published in the Washington Post in October, 2010

washingtonpost.com/../AR2010101905232.html